Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Primary composite score by gender and treatment groups. The entire group (men plus women) treated with isosorbide dinitrate/hydralazine (I/H) had a significantly improved the composite score (p = 0.016) compared with the entire group (men plus women) in the placebo arm. Women as a group had better composite scores than men (p = 0.049); however, there was no gender-by-treatment interaction (p = 0.806).
|
